The interplay of environmental luminance and genetics in the retinal dystrophy induced by the dominant RPE65 mutation

被引:4
|
作者
Wu, Wenjing [1 ]
Takahashi, Yusuke [1 ,2 ]
Shin, Henry Younghwa [1 ]
Ma, Xiang [1 ]
Moiseyev, Gennadiy [1 ]
Ma, Jian-Xing [1 ,2 ]
机构
[1] Univ Oklahoma, Dept Physiol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Harold Hamm Diabet Ctr, Hlth Sci Ctr, Oklahoma City, OK 73104 USA
关键词
retinal degeneration; photoreceptor; RPE65; visual cycle; RETINITIS-PIGMENTOSA; VISUAL CYCLE; LIGHT DAMAGE; ISOMEROHYDROLASE ACTIVITY; CONGENITAL AMAUROSIS; KEY RESIDUES; MOUSE MODEL; DEGENERATION; DISEASE; PROTEIN;
D O I
10.1073/pnas.2115202119
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The retinol isomerase retinal pigment epithelium (RPE) 65 is a key enzyme in the visual cycle that regenerates the chromophore, 11-cis-retinal, required for vision in all vertebrates. Mutations in RPE65 are associated with blinding diseases. D477G (C.1430G > A) is the only known RPE65 variant to cause autosomal dominant retinitis pigmentosa. Previously, we reported that heterozygous D477G knockin (KI) mice maintained in dim-light conditions exhibited delayed visual chromophore regeneration and slowed recovery of photoreceptor sensitivity following visual pigment photobleaching. However, heterozygous D477G KI mice did not manifest detectable decline in full field electroretinography (ERG) or in abnormal retinal structure, relative to the WT mice. In the present study, when maintained under the physiological relevant light intensity (2,000 lx), the heterozygous D477G KI mice displayed degenerative retina features, including reduced scotopic ERG amplitudes and thinning of the retinal layers, recapitulating that observed in human patients. In the same retinas, we also detected increased free opsin levels and up-regulated GFAP expression. Molecularly, we found reduced RPE65 and LRAT (lecithin: retinol acyltransferase) levels, decreased retinol isomerase activity, and altered subcellular localization and membrane association of RPE65 in the RPE of heterozygous D477G KI mice. Moreover, the D477G mutant, both in vivo and in vitro, formed protein complexes with WT-RPE65, leading to a reduction in RPE65 protein stability, which could not be completely rescued by the addition of MG132, a proteasome inhibitor of ubiquitin-dependent protein degradation. Altogether, our findings uncovered the dominant-negative nature of the D477G mutation and highlighted the importance of the light environment in the mechanism of its pathogenicity.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Absence of genotype-phenotype correlations in RPE65 gene mutations associated with autosomal recessive retinal dystrophy
    Chung, Daniel C.
    Trzupek, Karmen
    Wellman, Jennifer
    High, Katherine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [42] RPE65 gene:: multiplex PCR and mutation screening in patients from India with retinal degenerative diseases
    Joseph, B
    Srinivasan, A
    Soumittra, N
    Vidhya, A
    Shetty, NS
    Uthra, S
    Kumaramanickavel, G
    JOURNAL OF GENETICS, 2002, 81 (01) : 19 - 23
  • [43] Microdeletion in the RPE65 gene causing hereditary retinal dystrophy (HRD) disease segregates in the Polish population of Briards
    Switonski, M
    Konieczny, P
    Klukowska, J
    Janyga, B
    Aguirre, G
    MEDYCYNA WETERYNARYJNA, 2002, 58 (12) : 946 - 949
  • [44] Clinical Trial of Gene Therapy for Early Onset Severe Retinal Dystrophy Resulting from Defects in RPE65
    Ali, Robin R.
    Bainbridge, J. W. B.
    Smith, A. J.
    Fitzke, F. W.
    Holder, G. E.
    Stockman, A.
    Bhattacharya, S. S.
    Rubin, G. S.
    Yzer, S.
    van den Born, I.
    Moore, A. T.
    HUMAN GENE THERAPY, 2010, 21 (09) : 1174 - 1175
  • [45] Clinical trial of gene therapy for early onset severe retinal dystrophy resulting from defects in RPE65
    Ali, R. R.
    Bainbridge, J. W.
    Smith, A. J.
    Robbie, S.
    Fitzke, F. W.
    Holder, G. E.
    Stockman, A.
    Yzer, Z.
    Van den Born, I.
    Rubin, G. S.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1393 - 1393
  • [46] Myopic Macular Hole and Detachment after Gene Therapy in Atypical RPE65 Retinal Dystrophy: A Case Report
    Giansanti, Fabrizio
    Nicolosi, Cristina
    Giorgio, Dario
    Sodi, Andrea
    Mucciolo, Dario Pasquale
    Pavese, Laura
    Pollazzi, Liliana
    Virgili, Gianni
    Vicini, Giulio
    Passerini, Ilaria
    Pelo, Elisabetta
    Murro, Vittoria
    GENES, 2024, 15 (07)
  • [47] A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement
    Sara J Bowne
    Marian M Humphries
    Lori S Sullivan
    Paul F Kenna
    Lawrence C S Tam
    Anna S Kiang
    Matthew Campbell
    George M Weinstock
    Daniel C Koboldt
    Li Ding
    Robert S Fulton
    Erica J Sodergren
    Denis Allman
    Sophia Millington-Ward
    Arpad Palfi
    Alex McKee
    Susan H Blanton
    Susan Slifer
    Ioanna Konidari
    G Jane Farrar
    Stephen P Daiger
    Peter Humphries
    European Journal of Human Genetics, 2011, 19 : 1074 - 1081
  • [48] Phenotypic expansion of autosomal dominant retinitis pigmentosa associated with the D477G mutation in RPE65
    Jauregui, Ruben
    Cho, Ahra
    Oh, Jin Kyun
    Tanaka, Akemi J.
    Sparrow, Janet R.
    Tsang, Stephen H.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2020, 6 (01):
  • [49] Mechanism for a Dominant-Acting D477G Mutation in RPE65 Leading to Vision Impairment
    Nikolaeva, Olga
    Moiseyev, Gennadiy
    Takahashi, Yusuke
    Ma, Jian-Xing
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [50] Two point mutations of RPE65 from patients with retinal dystrophies decrease the stability of RPE65 protein and abolish its isomerohydrolase activity
    Takahashi, Yusuke
    Chen, Ying
    Moiseyev, Gennadiy
    Ma, Jian-Xing
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (31) : 21820 - 21826